| Not Yet Recruiting | Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma | Phase 2 | 2025-06-30 |
| Recruiting | Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Ind Colorectal Cancer | Phase 2 | 2024-04-16 |
| Active Not Recruiting | Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes A Metastatic Pancreatic Cancer | Phase 2 | 2022-11-28 |
| Recruiting | Spanish Registry of Digestive Tumours RETUD Digestive Cancers, Bile Duct Cancer, Hepatocellular Cancer (HCC) | — | 2020-12-23 |
| Active Not Recruiting | Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus F Colorectal Cancer | Phase 3 | 2018-10-15 |
| Completed | Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment Wi Metastatic Colorectal Cancer | Phase 2 | 2017-10-25 |
| Completed | Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Color Metastatic Colorectal Cancer | Phase 2 | 2016-11-01 |
| Completed | Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC Metastatic Colorectal Cancer | Phase 2 | 2016-07-01 |
| Completed | Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreat Metastatic Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2015-07-01 |
| Terminated | Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Colorectal Neoplasms, Metastatic Disease | Phase 2 | 2014-06-01 |
| Completed | Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer Colorectal Neoplasms, Metastatic Disease | Phase 2 | 2013-06-01 |
| Completed | Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Re Stage IV Colorectal Cancer | Phase 2 | 2012-10-01 |
| Completed | Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bev Colorectal Cancer Metastatic | Phase 2 | 2012-07-01 |
| Completed | Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxalipl Metastatic Colorectal Cancer | Phase 3 | 2012-07-01 |
| Terminated | Axitinib as Maintenance Treatment in Patients With Metastatic CRC Colorectal Carcinoma | Phase 2 | 2012-02-01 |
| Completed | Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer | Phase 2 | 2011-02-01 |
| Completed | Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Sin Metastatic Colorectal Cancer | Phase 2 | 2010-08-01 |
| Completed | Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorecta Colorectal Cancer | Phase 2 | 2010-05-01 |
| Completed | Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxalipla Colorectal Cancer | Phase 2 | 2010-02-01 |
| Completed | Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiot Rectal Cancer | Phase 2 | 2009-12-01 |
| Completed | Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Canc Metastatic Colorectal Cancer | Phase 2 | 2009-08-01 |
| Completed | Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer Colorectal Cancer | Phase 2 | 2009-05-01 |
| Completed | Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients Metastatic Colorectal Cancer | Phase 2 | 2009-04-01 |
| Completed | Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Adva Gastric Cancer | Phase 2 | 2008-11-01 |
| Terminated | Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Metastatic Colorectal Cancer | Phase 2 | 2007-11-01 |
| Completed | Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC Metastatic Colorectal Cancer | Phase 2 | 2007-05-01 |
| Completed | A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Esophageal Carcinoma | Phase 2 | 2006-12-01 |
| Completed | Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colo Colorectal Cancer | Phase 3 | 2006-07-01 |
| Completed | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer Colorectal Cancer | Phase 2 | 2005-02-01 |
| Completed | Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Ca Colorectal Cancer | Phase 3 | 2002-04-01 |